Cargando…

The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication

BACKGROUND: Individuals with hypertrophic cardiomyopathy (HCM), even when asymptomatic, are at‐risk for sudden cardiac death and stroke from arrhythmias, making it imperative to identify individuals affected by this familial disorder. Consensus guidelines recommend that first‐degree relatives (FDRs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Stephanie, Cirino, Allison L., Carr, Christina W., Tafessu, Hiwot M., Parmar, Siddharth, Greenberg, Jeffrey O., Szent‐Gyorgyi, Lara E., Ghazinouri, Roya, Glowny, Michelle G., McNeil, Kara, Kaynor, Efthalia F., Neumann, Catherine, Seidman, Christine E., MacRae, Calum A., Ho, Carolyn Y., Lakdawala, Neal K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825857/ https://www.ncbi.nlm.nih.gov/pubmed/31482667 http://dx.doi.org/10.1002/mgg3.940

Ejemplares similares

The Early History of the Biochemistry of Muscle Contraction
por: Szent-Györgyi, Andrew G.
Publicado: (2004)

Activation of the Adenosine Triphosphatase of Limulus polyphemus Actomyosin by Tropomyosin
por: Lehman, William, et al.
Publicado: (1972)

Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish
por: Becker, Jason R., et al.
Publicado: (2011)

Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
por: Litt, Michael J, et al.
Publicado: (2023)

Fluorogenic Dendrons with Multiple Donor Chromophores as Bright Genetically Targeted and Activated Probes
por: Szent-Gyorgyi, Christopher, et al.
Publicado: (2010)

ALU transposition induces familial hypertrophic cardiomyopathy
por: Nfonsam, Landry, et al.
Publicado: (2019)

Familial Hypertrophic Cardiomyopathy With Fasciculoventricular Accessory Pathway
por: Kalra, Vikas, et al.
Publicado: (2022)

Familial risk of dilated and hypertrophic cardiomyopathy: a national family study in Sweden
por: Ricci, Fabrizio, et al.
Publicado: (2022)

Sex Differences in Hypertrophic Cardiomyopathy: Interaction With Genetics and Environment
por: Butters, Alexandra, et al.
Publicado: (2021)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Multinational Federated Learning Approach to Train ECG and Echocardiogram Models for Hypertrophic Cardiomyopathy Detection
por: Goto, Shinichi, et al.
Publicado: (2022)

Parsing cell death in arrhythmogenic cardiomyopathy: PANoptosis
por: MacRae, Calum A.
Publicado: (2023)

Hypertrophic cardiomyopathy: Translating cellular cross talk into therapeutics
por: Teekakirikul, Polakit, et al.
Publicado: (2012)

Extreme septal hypertrophy in an adolescent with congenital familial hypertrophic cardiomyopathy
por: Park, Byoung-Won, et al.
Publicado: (2015)

Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
por: Lafreniere-Roula, Myriam, et al.
Publicado: (2019)

Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers
por: Chaves-Markman, Ândrea, et al.
Publicado: (2020)

Family screening of hypertrophic cardiomyopathy in children: a case report
por: Voges, Inga, et al.
Publicado: (2022)

Development of Standardized Clinical Assessment and Management Plans (SCAMPs) in Plastic and Reconstructive Surgery
por: Caterson, Stephanie A., et al.
Publicado: (2015)

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
por: Ho, Carolyn Y., et al.
Publicado: (2018)

The relationship between parental disability and child outcomes: Evidence from veteran Families
por: Lakdawala, Leah K., et al.
Publicado: (2022)

Serial Observations and Mutational Analysis of an Adoptee with Family History of Hypertrophic Cardiomyopathy
por: Harris, Bronwyn, et al.
Publicado: (2010)

Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy
por: Magida, Jason A, et al.
Publicado: (2014)

Pathogenic variant of RBM20 in a multiplex family with hypertrophic cardiomyopathy
por: Inagaki, Natsuko, et al.
Publicado: (2022)

Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance( )
por: Huurman, Roy, et al.
Publicado: (2022)

Development of Standardized Clinical Assessment and Management Plans (SCAMPs) in the Field of Plastic & Reconstructive Surgery: A Quality Improvement Project: Erratum
por: Caterson, Stephanie A., et al.
Publicado: (2016)

The developmental basis of adult arrhythmia: atrial fibrillation as a paradigm
por: Kapur, Sunil, et al.
Publicado: (2013)

Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs
por: Kithcart, Aaron, et al.
Publicado: (2017)

Reasons for Guideline Nonadherence at Heart Failure Discharge
por: Gilstrap, Lauren G., et al.
Publicado: (2018)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene
por: Ehlermann, Philipp, et al.
Publicado: (2008)

Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants
por: Kraker, Jessica, et al.
Publicado: (2016)

Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3
por: Aurensanz Clemente, Esther, et al.
Publicado: (2017)

Potential digenic inheritance of familial hypertrophic cardiomyopathy identified by whole‐exome sequencing
por: Ren, Ming‐Bao, et al.
Publicado: (2020)

Therapeutic Strategies by Regulating Interleukin Family to Suppress Inflammation in Hypertrophic Scar and Keloid
por: Zhang, Dan, et al.
Publicado: (2021)

Improving Influenza and Pneumococcal Vaccination Rates in Ambulatory Specialty Practices
por: Pennant, Keyana N., et al.
Publicado: (2015)

Deletion of entire LMNA gene as a cause of cardiomyopathy
por: Cirino, Allison L., et al.
Publicado: (2020)

Unequal allelic expression of wild-type and mutated β-myosin in familial hypertrophic cardiomyopathy
por: Tripathi, Snigdha, et al.
Publicado: (2011)

Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
por: Han, Lu, et al.
Publicado: (2014)

Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation
por: Hill, Meghan G., et al.
Publicado: (2015)

Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body
por: Oikawa, Masayoshi, et al.
Publicado: (2016)

Hypertrophic Olivary Degeneration and Movement Disorder in a Patient with Familial Creutzfeldt-Jakob Disease
por: Granger, Andre, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sjkfqb6ar4mkvj922v3l6ipce1